Skip to main content
Premium Trial:

Request an Annual Quote

Pfizer Licenses Ariadne's Pathway Studio Software

NEW YORK (GenomeWeb News) – Pfizer has bought a multi-site license for Ariadne’s Pathway Studio Enterprise software, which is used to import and analyze microarray and proteomics data and includes the ResNet database, Rockville, Md.-based Ariadne said yesterday.
 
Pfizer plans to use the software to assemble reference networks of interactions from internal and public data sources to interpret experimental results in its labs.
 
Ariadne President Ilya Mazo said the software allows pharmaceutical companies to integrate information from their databases, experimental data, and their custom-made datasets.
 
Financial terms of the agreement were not released.

The Scan

Not Yet a Permanent One

NPR says the lack of a permanent Food and Drug Administration commissioner has "flummoxed" public health officials.

Unfair Targeting

Technology Review writes that a new report says the US has been unfairly targeting Chinese and Chinese-American individuals in economic espionage cases.

Limited Rapid Testing

The New York Times wonders why rapid tests for COVID-19 are not widely available in the US.

Genome Research Papers on IPAFinder, Structural Variant Expression Effects, Single-Cell RNA-Seq Markers

In Genome Research this week: IPAFinder method to detect intronic polyadenylation, influence of structural variants on gene expression, and more.